重组全人源抗新型冠状病毒单克隆抗体注射液(F61注射液)治疗新型冠状病毒感染合并肾损伤患者的有效性和安全性：一项随机对照的探索性临床研究

Chinese Journal of Infection Control ›› 2024, Vol. 23 ›› Issue (03) : 257-264.

Author information +
History +

CLC number

R511 / R692

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Comments

Accesses

Citation

Detail
Sections
Recommended
Copyright © Chinese Journal of Infection Control, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉